Immunotherapy with a standardized extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children

Roches, Anne Des; Paradis, Louis; Menardo, Jean‐Luc; Bouges, Stéphane; Daurès, Jean‐Pierre; Bousquet, Jean

doi:10.1016/s0091-6749(97)70069-1

Cited by 529 publications

(326 citation statements)

References 24 publications

Supporting

Mentioning

301

Contrasting

Unclassified

Order By: Relevance

“…First, SIT can modify the natural history of allergic disease, as confirmed in rigorously conducted trials (13,14). Second, SIT can prevent the onset of new sensitizations, as demonstrated clearly in children in several studies (15,16). Third, SIT even maintains its clinical efficacy years after discontinuation.…”

Section: Discussionmentioning

confidence: 86%

See 1 more Smart Citation

Effects of Allergen Specific Immunotherapy on the Allergens Excluded From the Treatment

et al. 2008

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 86%

“…Des Roches et al (15) has been studied in children with allergic asthma. In this study 22 child with asthma monosensitized to house dust mite and these children younger than 6 years of age who received SIT were evaluated prospectively and compared with 22 children monosensitized to house dust mite who were not treated with SIT.…”

Section: Discussionmentioning

confidence: 99%

Effects of Allergen Specific Immunotherapy on the Allergens Excluded From the Treatment

et al. 2008

View full text Add to dashboard Cite

“…Следует учитывать и наличие в патогенезе заболева-ния нейрогенного компонента, проявляющегося через высвобождение нейропептидов из окончаний холинер-гических и пептидергических нейронов [9]. Патофизио-логический механизм аллергического ринита представ-лен ниже (рис.…”

Section: классификация аллергического ринита формы аллергического ринитаunclassified

Allergic rhinitis: a new solution to an old problem

Туровский¹

2016

Med. sov.

View full text Add to dashboard Cite

“…9,47 El efecto preventivo del desarrollo de nuevas sensibilizaciones fue demostrado tanto para la modalidad subcutánea 48,51 como sublingual. 52 Los cambios inmunológicos provocados por la inmunoterapia se han observado desde los primeros años de la vida.…”

Section: Intervención Inmunológica Inmunoterapia Alérgeno Específicaunclassified

Prevención de las enfermedades alérgicas en la infancia: entre la teoría y la realidad

2016

Arch Argent Pediat

View full text Add to dashboard Cite

RESUMENLas enfermedades alérgicas tienen una prevalencia creciente de modo universal y ocasionan alto impacto sanitario. La investigación está dirigida al estudio de los factores etiológicos y de riesgo de estas enfermedades, que pueden ser potencialmente modificados con estrategias de prevención primaria, secundaria y terciaria. Muchas de esas medidas no tienen un efecto comprobado de manera definitiva, dado que se realizan en un contexto controlado diferente a lo que ocurre en la vida real. Este documento tiene por objetivo revisar las evidencias más actuales sobre prevención de las enfermedades alérgicas considerando las certezas y cuestiones por resolver, y está especialmente centrado en las medidas ambientales, dietéticas, farmacológicas e inmunológicas para los distintos niveles preventivos. Es imperativo un mejor conocimiento de genes y factores ambientales responsables de las enfermedades alérgicas para optimizar las medidas preventivas que permitan revertir la creciente prevalencia de estas enfermedades en la infancia. Palabras clave: alergia, prevención, asma, control ambiental, inmunoterapia. ABSTRACTAllergic diseases have an increasing worldwide prevalence and a great impact on the health related costs. The research is focused on the study of etiological and risk factors of allergic diseases that can potentially be modified with primary, secondary and tertiary prevention strategies. Many of these measures do not have a definitively proven effect taking place in a controlled context different to what happens in real life. This paper aims to review the latest evidence on prevention of allergic diseases considering certainties and unresolved issues and focuses mainly on environmental, dietary, pharmacological and immunological preventive strategies for different levels of prevention. It is imperative to have a better understanding of genetic and environmental factors that cause allergic diseases to optimize preventive measures that are effective in reversing the increasing trend in the prevalence of allergic illnesses in childhood. Key words : allergy, prevention, asthma, environmental control, immunotherapy. http://dx.doi.org/10.5546/aap.2016.277 INTRODUCCIÓNL a s e n f e r m e d a d e s a l é r g i c a s constituyen las patologías crónicas más frecuentes en la edad pediátrica, c o n e l e v a d o s c o s t o s s a n i t a r i o s para el diagnóstico y tratamiento y afectación de la calidad de vida.1 . En Latinoamérica, aproximadamente el Comité Nacional de Alergia Documento de toma de posición Documento desarrollado en el marco del 50° aniversario del

show abstract

Immunotherapy with a standardized extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children

Cited by 529 publications

References 24 publications

Effects of Allergen Specific Immunotherapy on the Allergens Excluded From the Treatment

Effects of Allergen Specific Immunotherapy on the Allergens Excluded From the Treatment

Allergic rhinitis: a new solution to an old problem

Prevención de las enfermedades alérgicas en la infancia: entre la teoría y la realidad

Contact Info

Product

Resources

About